ASO Author Reflections: The Changing Role of Gene Expression Profiling in ER+/HER2- Breast Cancer

Ann Surg Oncol. 2019 Dec;26(Suppl 3):800-801. doi: 10.1245/s10434-019-07955-y. Epub 2019 Oct 24.

Authors

Julia E C van Steenhoven^{1

2}, T van Dalen³

Affiliations

¹ Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. juliavansteenhoven@gmail.com.
² Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. juliavansteenhoven@gmail.com.
³ Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

No abstract available

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor / genetics*
Breast Neoplasms / drug therapy*
Breast Neoplasms / genetics
Breast Neoplasms / metabolism
Breast Neoplasms / pathology
Decision Making*
Female
Gene Expression Profiling*
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Prognosis
Receptor, ErbB-2 / metabolism*
Receptors, Estrogen / metabolism*

Substances

Biomarkers, Tumor
Receptors, Estrogen
ERBB2 protein, human
Receptor, ErbB-2